Skip to main content
. 2016 Jul 22;60(8):4793–4798. doi: 10.1128/AAC.00671-16

TABLE 2.

Microbiological features of representative Ureaplasma isolates of the study

Species and isolate no. Specimen sourcea MIC (μg/ml)b
tet(M) QRDRc
MLST
LEV CIP TET DOX ERY AZM gyrA gyrB parC parE ftsH rpl22 valS rprS STd
U. parvum
    IDRL-10860 Urine 4 16 ≤0.125 ≤0.125 0.5 0.5 WT WT S83L WT 1 1 1 1 ST1
    IDRL-10857 Vagina 4 16 0.5 0.25 2 2 WT WT S83L WT 35 1 1 1 ST95
    IDRL-10940 Vagina 8 16 ≤0.125 ≤0.125 0.5 0.5 WT WT S83L WT 8 1 1 1 ST56
    IDRL-10790 Urethra 4 16 ≤0.125 ≤0.125 0.5 0.5 WT WT S83L WT 8 1 1 1 ST56
    IDRL-10904 Cervix 4 16 8 2 0.5 0.5 + WT WT S83L WT 2 1 1 1 ST2
    IDRL-11151 Cervix 4 16 ≤0.125 ≤0.125 0.5 0.5 WT WT S83L WT 1 1 1 1 ST1
    IDRL-11156 Urine 4 16 ≤0.125 ≤0.125 2 1 WT WT S83L WT 8 1 1 1 ST56
    IDRL-11160 Urine 16 >16 ≤0.125 ≤0.125 1 0.5 WT WT S83L WT 2 1 22e 1 ST108f
    IDRL-11170 Vagina 8 16 ≤0.125 ≤0.125 0.25 0.25 WT WT S83L WT 1 2 1 1 ST22
    IDRL-11178 Vagina 4 16 ≤0.125 ≤0.125 0.5 0.5 + WT WT S83L WT 1 1 1 1 ST1
    IDRL-11211 Vagina 4 16 ≤0.125 ≤0.125 1 0.5 WT WT S83L WT 1 1 23e 1 ST109f
    IDRL-11260 Vagina 8 16 ≤0.125 ≤0.125 2 2 WT WT S83L WT 1 12 1 1 ST103
    IDRL-11232 Cervix 8 16 ≤0.125 ≤0.125 1 1 WT WT E87K WT 20 2 1 1 ST111f
    IDRL-11141 Vagina 0.5 2 0.25 ≤0.125 1 1 + ND ND ND ND 2 2 1 2 ST105
    IDRL-11142 Vagina 0.5 2 0.25 ≤0.125 0.5 0.5 + ND ND ND ND 2 2 1 1 ST4
    IDRL-11149 Urine 0.5 2 0.25 ≤0.125 1 1 + ND ND ND ND 8 1 1 1 ST56
    IDRL-11152 Cervix 0.5 2 0.25 ≤0.125 0.5 0.5 + ND ND ND ND 2 2 1 1 ST4
    IDRL-11177 Urine 0.5 2 ≤0.125 ≤0.125 0.5 0.5 + ND ND ND ND 8 1 1 1 ST56
    IDRL-11179 Vagina 0.5 2 ≤0.125 ≤0.125 0.5 0.25 + ND ND ND ND 2 1 1 2 ST38
    IDRL-11252 Vagina 0.25 0.5 ≤0.125 ≤0.125 0.25 0.25 + ND ND ND ND 2 14e 1 1 ST110f
    IDRL-11268 Vagina 0.5 2 ≤0.125 ≤0.125 2 2 + ND ND ND ND 2 2 1 1 ST4
    IDRL-10852 Vagina 0.25 2 ≤0.125 ≤0.125 2 2 ND ND ND ND 2 2 1 1 ST4
    IDRL-10835 Cervix 2 8 ≤0.125 ≤0.125 0.5 0.5 WT WT WT WT 1 1 1 1 ST1
    IDRL-10774 BAL 0.25 2 ≤0.125 ≤0.125 0.5 0.5 ND ND ND ND 1 2 1 1 ST22
    IDRL-10874 Vagina 0.5 2 ≤0.125 ≤0.125 0.5 0.25 ND ND ND ND 1 1 1 1 ST1
    IDRL-10923 Cervix 0.25 1 ≤0.125 ≤0.125 0.25 0.25 ND ND ND ND 2 1 1 1 ST2
    IDRL-11125 Cervix 0.25 2 ≤0.125 ≤0.125 1 1 ND ND ND ND 2 14e 1 1 ST110f
    IDRL-11207 Vagina 1 4 ≤0.125 ≤0.125 1 0.5 ND ND ND ND 1 2 1 1 ST22
    IDRL-11257 TA 0.5 2 ≤0.125 ≤0.125 0.25 0.25 ND ND ND ND 1 1 1 1 ST1
    IDRL-11271 Cervix 0.5 2 ≤0.125 ≤0.125 2 2 ND ND ND ND 2 1 1 1 ST2
U. urealyticum
    IDRL-10763 BAL 4 16 0.25 ≤0.125 2 2 WT WT S83L WT 5 3 4 5 ST7
    IDRL-11217 Urine 4 16 0.25 ≤0.125 2 2 WT WT WT WT 5 3 4 4 ST47
    IDRL-10967 Vagina 2 8 0.5 ≤0.125 2 2 WT WT WT WT 5 3 4 4 ST47
    IDRL-11184 Vagina 2 8 0.5 ≤0.125 2 2 WT WT WT WT 5 3 4 4 ST47
    IDRL-11235 TA 0.5 4 0.25 ≤0.125 2 2 ND ND ND ND 42e 3 4 18e ST112f
    IDRL-11135 Urine 1 4 0.5 ≤0.125 2 2 ND ND ND ND 6 3 4 11 ST54
    IDRL-10787 Cervix 2 8 0.25 ≤0.125 1 1 ND ND ND ND 5 3 4 4 ST47
    IDRL-10928 Urine 0.5 2 0.25 ≤0.125 0.25 0.25 ND ND ND ND 4 11 4 4 ST113f
    IDRL-11163 Cervix 0.5 4 ≤0.125 ≤0.125 1 1 ND ND ND ND 4 3 4 4 ST9
    IDRL-11213 Vagina 0.5 4 0.25 ≤0.125 2 2 ND ND ND ND 41 3 4 11 ST101
    IDRL-11269 Cervix 0.5 2 0.5 ≤0.125 2 2 ND ND ND ND 6 3 4 11 ST54
    IDRL-11295 Urine 0.5 2 ≤0.125 ≤0.125 1 1 ND ND ND ND 42e 3 4 18e ST112f
    IDRL-11298 Urine 0.5 2 ≤0.125 ≤0.125 2 1 ND ND ND ND 5 3 4 4 ST47
    IDRL-11299 Urine 0.5 2 ≤0.125 ≤0.125 1 0.5 ND ND ND ND 4 3 4 4 ST9
    IDRL-11306 Urine 0.5 2 ≤0.125 ≤0.125 1 0.5 ND ND ND ND 5 3 4 5 ST7
    IDRL-11308 Urine 2 8 0.25 ≤0.125 1 0.5 ND ND ND ND 4 3 4 4 ST9
a

BAL, bronchoalveolar lavage fluid; TA, tracheal aspirate.

b

LEV, levofloxacin; CIP, ciprofloxacin; TET, tetracycline; DOX, doxycycline; ERY, erythromycin; AZM, azithromycin.

c

WT, wild type; ND, not done.

d

ST, sequence type.

e

New alleles; numbering starts from the last alleles reported by Zhang et al. (17) and Schneider et al. (9).

f

New STs; numbering starts from the last profiles reported by Zhang et al. (17) and Schneider et al. (9).